Defective bone mineralization and osteopenia in young adult FGFR3 -/- mice

Human Molecular Genetics

Volumn 13, Issue 3, 2004, Pages 271-284

  Valverde Franco, Gladys ^a,b   Liu, Hanlong ^a,b   Davidson, David ^a,b   Chai, Sen ^a   Valderrama Carvajal, Hector ^a,b   Goltzman, David ^a,b   Ornitz, David M ^c   Henderson, Janet E ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE GROWTH; BONE MARROW; BONE MINERALIZATION; BONE REMODELING; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; CRANIAL SUTURE; DWARFISM; GENE MUTATION; GENE TARGETING; HISTOCHEMISTRY; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LONG BONE; MALE; MOLECULAR BIOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOID; OSTEOPENIA; PERINATAL PERIOD; PRIORITY JOURNAL; TRABECULAR BONE;

ANIMALS; BONE DISEASES, METABOLIC; CALCIFICATION, PHYSIOLOGIC; FEMUR; MICE; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; STROMAL CELLS; TIBIA;

ANIMALIA;

EID: 1042280310     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh034     Document Type: Article

References (81)

1. Baird, A. and Ornitz, D.M. (2000) Fibroblast growth factors and their receptors. In Canalis E. (ed.), Skeletal Growth Factors. Lipincott Williams and Wilkins, Philadelphia, PA, pp. 167-178.
2. Ornitz, D. and Itoh, N. (2001) Fibroblast growth factors. Genome Biol., 2, Reviews S3005.
3. Kanai, M., Gooke, M., Tsunekawa, S. and Podolsky, D.K. (1997) Signal transduction pathway of human fibroblast growth factor 3. J. Biol. Chem., 272, 6621-6628.
4. 2+ flux but not mitogenesis. Nature, 358, 678-681.
5. Su, W.C.S., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W.A. and Fu, X.Y. (1997) Activation of STAT-1 by mutant fibroblast growth factor receptor in thanatophoric dysplasia typeII dwarfism. Nature, 386, 288-292.
6. Peters, K.G., Werner, S., Chen, G. and Williams, L.T. (1992) Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissue during limb formation and organogenesis in the mouse. Development, 114, 233-243.
7. Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A., Coulier, F., Gao, G. and Goldfarb, M. (1996) Receptor specificity of the fibroblast growth factor family. J. Biol. Chem., 271, 15292-15297.
8. Ornitz, D.M. (2000) FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays, 22, 108-112.
9. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P. and Ornitz, D.M. (1991) Cell suface heparan-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848.
10. Nguyen, H.B., Estacion, M. and Gargus, J.J. (1997) Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts. Human Mol. Genet., 6, 681-688.
11. Pandit, S.G., Govinraj, P., Sasse, J., Neame, P.J. and Hassell, J.R. (2002) The fibroblast growth factor receptor 3, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs. Biochem. J., 361, 231-241.
12. Peters, K., Ornitz, D., Werner, S. and Williams, L. (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol., 155, 423-430.
13. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84, 911-921.
14. Delezoide, A.L., Lasselin, C.B., Mallet, L.L., Merrer, M.L., Munnich, A., Vekemans, M. and Bonaventure, J. (1998) Spatio temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Develop., 77, 19-30.
15. Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E.N., Towler, D.A. and Ornitz, D.M. (2003) Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development, 130, 3063-3074.
16. Rice, D.P.C., Aberg, T., Chan, Y.S., Tang, Z., Kettunen, P.J., Pakarinen, L., Maxson, R.E. and Theleff, I. (2000) Integration of FGF and twist in calvarial bone and suture development. Development, 127, 1845-1855.
17. Ornitz, D.M. and Marie, P.J. (2002) FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev., 16, 1446-1465.
18. Rousseau, F., Bonaventure, J., Legeal-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., Merrer, M.L. and Munnich, A. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature, 371, 252-254.
19. Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S.T. and Wasmuth, J.J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell, 78, 335-342.
20. Amizuka, N., Chen, M.F., Goodyer, C., Sasaki, T., Asawa, Y., Franco-Valverde, G. and Henderson, J.E. (2001) Abnormalities in development of the growth plates of thanatophoric dysplasia type II fetuses result from enhanced vascular invasion and osteoclastic activity. J. Bone Miner. Res., 16, S1.
21. Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G. and Ornitz, D.M. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet., 12, 390-397.
22. Amizuka, N., Davidson, D., Liu, H., Valverde-Franco, G., Chai, S., Sasaki, T., Ozawa, H., Hammond, V., Ornitz, D.M., Goltzman, D. and Henderson, J.E. (2003) Signaling by fibroblast growth factor receptor 3 (FGFR3) and parathyroid hormone related protein (PTHrP) coordinate cartilage and bone development. Bone, (in press).
23. Naski, M.C., Colvin, J., Coffin, J. and Ornitz, D.M. (1998) Repression of hedgehog signalling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development, 125, 4977-4988.
24. Li, C., Chen, L., Iwata, T., Kitagawa, M., Fu, X.-Y. and Deng, C.-X. (1999) A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and Ink4 cell cycle inhibitors. Hum. Mol. Genet., 8, 35-44.
25. Chen, L., Li, C., Qiao, W., Xu, X. and Deng, C. (2001) A Ser365 to Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum. Mol. Genet., 10, 457-465.
26. Iwata, T., Li, C.-L., Deng, C.-X. and Francomano, C. (2001) Highly activated FGFR3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum. Mol. Genet., 10, 1255-1264.
27. Sabbieti, M.G., Marchetti, L., Abreu, C., Montero, A., Hand, A.R., Raisz, L.G. and Hurley, M.M. (1999) Prostaglandins regulate the expression of fibroblast growth factor 2 in bone. Endocrinology, 140, 434-444.
28. Twal, W.O., Vasilatos-Younken, R., Gay, C.V. and Leach, R.M., Jr (1994) Isolation and localization of basic fibroblast growth factor-immunoreactive substance in the epiphyseal growth plate. J. Bone Mineral Res., 9, 1737-1744.
29. Montero, A., Okada, Y., Tomita, M., Ito, M., Tsurukami, H., Nakamura, T., Doetschman, T., Ciffin, J. and Hurley, M. (2000) Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest., 105, 1085-1093.
30. Liu, Z., Xu, J., Colvin, J.S. and Ornitz, D.M. (2002) Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev., 16, 859-869.
31. Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N. and Takada, S. (2002) FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev., 16, 870-879.
32. Baron, R. (1999) Anatomy and ultrastructure of bone. In Favus, M.J. (ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Vol. 4. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 3-10.
33. Marks, S. and Odgren, P. (2002) Structure and development of the skeleton. In Bilezekian, J., Raisz, L. and Rodan, G. (eds), Principles of Bone Biology, Vol. 2. Academic Press, San Diego, CA, pp. 3-16.
34. Mundy, G.R. (1999) Bone remodeling. In Favus, M.J. (ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Vol. 4. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 30-38.
35. Shapiro, E. (1997) Variable conformation of GAP junctions linking bone cells: a transmission electron microscopic study of linear, stacked linear, curvilinear, oval and annular junctions. Cal. Tiss. Int., 61, 285-293.
36. Robling, A.G. and Turner, C.H. (2002) Mechanotransduction in bone: genetic effects on mechanosensitivity in mice. Bone, 31, 562-569.
37. Zhao, W., Byrne, M.H., Wang, Y. and Krane, S.M. (2000) Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J. Clin. Invest., 106, 941-949.
38. Erlebacher, A., Filvaroff, E.H., Ye, J.Q. and Derynck, R. (1998) Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell, 9, 1903-1918.
39. Mansukhani, A., Bellosta, P., Sahni, M. and Basilico, C. (2000) Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2) activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol., 149, 1297-1308.
40. Hurley, M., Tetradis, S., Huang, Y., Hock, J., Kream, B., Raisz, L. and Sabbieti, M. (1999) Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J. Bone Miner. Res., 14, 776-783.
41. Walsh, S., Jefferiss, C., Stewart, K., Jordan, G.R., Screen, J. and Beresford, J.N. (2000) Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone, 27, 185-195.
42. Stanislaus, D., Yang, X., Liang, J.D., Wolfe, J., Cain, R.L., Onyia, J.E., Falla, N., Marder, P., Bidwell, J.P., Queener, S.W. and Hock, J.M. (2000) In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone, 27, 209-218.
43. Sobue, T., Gravely, T., Hand, A., Min, Y.K., Pilbeam, C., Raisz, L.G., Zhang, X., Larocca, D., Florkiewicz, R. and Hurley, M.M. (2002) Regulation of fibroblast growth factor 2 and fibroblast growth factor resceptors by transforming growth factor beta in human osteoblastic MG-63 cells. J. Bone Miner. Res., 17, 502-5122.
44. Iseki, S., Wilkie, A.O.M. and Morris-Kay, G.M. (1999) FGFR1 and FGFR2 have distinct differentiation and proliferation-related roles in the developing mouse skull vault. Development, 126, 5611-5620.
45. Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rissini, G., Boyce, B., Zhao, M. and Gutierrez, G. (1999) Stimulation of bone formation in vitro and in rodents by statins. Science, 286, 1946-1949.
46. Chikazu, D., Hakeda, Y., Ogata, N., Nemoto, K., Itabashi, A., Takato, T., Kumegawa, M., Nakamura, K. and Kawaguchi, H. (2000) Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J. Biol. Chem., 275, 31444-31450.
47. Shimoaka, T., Ogasawara, T., Yonamine, A., Chikazu, D., Kawano, H., Nakamura, K., Itoh, N. and Kawaguchi, H. (2002) Regulation of osteoblast, chondrocyte and osteoclast functions by fibroblast growth factor (FGF) 18 in comparison with FGF2 and FGF10. J. Biol. Chem., 277, 7493-7500.
48. Okada, Y., Montero, A., Zhang, X., Sobue, T., Lorenzo, J., Doetschman, T., Coffin, J.D. and Hurley, M.M. (2003) Impaired osteoclast formation in bone marrow cultures of FGF2 null mice in response to parathyroid hormone. J. Biol. Chem., 278, 21258-21266.
49. Takahashi, N., Udagawa, N., Takami, M., and Suda, T. (2002) Cells of bone: osteoclast generation. In Bilezekian, J.P., Raisz, L.G. and Rodan, G.A. (eds). Principles of Bone Biology, Vol. 1 Academic Press, San Diego, CA, pp. 109-126.
50. Jergas, M.D. and Genant, H.K. (1999) Radiology of osteoporosis. In Favus, M.J. (ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Vol. 4. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 160-169.
51. DiMeglio, L.A., White, K.E. and Econs, M.J. (2000) Disorders of phosphate metabolism. Endocrinol. Metab. Clin. N. Am., 29, 591-609.
52. Consortium, A. (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF-23. Nat. Genet., 26, 345-348.
53. Jonsson, K.B., Zahradnik, R., Larsson, T., White, K.E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, O. et al. (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and x-linked hypoplisphatemia. New Engl. J. Med., 348, 1656-1663.
54. Riminucci, M., Collins, M.T., Fedarko, N.S., Cherman, N., Corsi, A., White, K.E., Waguespack, S., Gupta, A., Hannon, T., Econs, M.J., Bianco, P. and Robey, P.G. (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest., 112, 683-692.
55. Webber, T.J., Liu, S., Indridason, O.S. and Quarles, L.D. (2003) Serum FGF23 levels in normal and disordered phosphate homeostasis. J. Bone Miner. Res., 18, 1227-1234.
56. Canalis, E., McCarthy, T. and Centrella, M. (1988) Growth factors and the regulation of bone remodelling. J. Clin. Invest., 81, 277-281.
57. Schmitt, J.M., Hwang, K., Winn, S.R. and Hollinger, J.O. (1999) Bone morphogenetic proteins: an update on basic biology and clinical relevance. J. Orthoped. Res., 17, 269-278.
58. Hurley, M., Marie, P. and Florkiewicz, R. (2002) Fibroblast growth factor (FGF) and FGF receptor families in bone. In Bilezekian, J., Raisz, L. and Rodan, G. (eds), Principles of Bone Biology, Vol. 2. Academic Press, San Francisco, CA, pp. 825-851.
59. Manolagas, S.C. and Jilka, R.J. (1995) Bone marrow cytokines and bone remodeling. New Engl. J. Med., 332, 305-311.
60. Miao, D., Bai, X., Panda, D., McKee, M., Karaplis, A. and Goltzman, D. (2001) Osteomalacia in Hyp mice is associated with abnormal Phex expression and deposition. Endocrinology, 142, 926-939.
61. Panda, D., Miao, D., Tremblay, M.L., Sirois, J., Farooldii, R., Hendy, G.N. and Goltzman, D. (2001) Targeted ablation of the 25-hydroxyvitamin D 1a hydroxylase enzyme: evidence for skeletal, reproductive and immune dysfunction. Proc. Natl Acad. Sci. USA, 98, 7498-7503.
62. Dardenne, O., Prudhomme, J., Arabian, A., Glorieux, F.H. and Arnaud, R.S. (2001) Targeted inactivation of the 25-hydroxyvitamin Ds 1a hydroxylase gene (CYP27B1) creates an animal model of pseudo vitamin D deficiency rickets. Endocrinology, 142, 3135-3141.
63. Wang, D., Canaff, L., Davidson, D., Corluka, A., Liu, H., Hendy, G.N. and Henderson, J.E. (2001) Alterations in the sensing and transport of phosphate and calcium by differentiating chondrocytes. J. Biol. Chem., 276, 33995-34005.
64. Montessuit, C., Bonjour, J.P. and Caverzasio, J. (1995) Expression and regulation of Na-dependent Pi transport in matrix vesicles produced by osteoblast-like cells. J. Bone Miner. Res., 10, 625-631.
65. Ruchon, A.F., Marcinkiewicz, M., Siegfried, G., Tenenhouse, H.S., desGroseillers, L., Crine, P. and Boileau, G. (1998) Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J. Histochem. Cytochem., 46, 459-468.
66. Ecarot, B. and Desbarats, M. (1999) 1,25(OH)2D3 down regulates expression of Phex, a marker of the mature osteoblast. Endocrinology, 140, 1192-1199.
67. Rittling, S.R., Matsumoto, H.N., McKee, M.D., Nanci, A., An, X.R., Novick, K.E., Kowalski, A.J., Noda, M. and Denhardt, D.T. (1998) Mice lacking OPN show normal development and bone structure but show altered osteoclast formation in vitro. J. Bone Miner. Res., 13, 1101-1111.
68. Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., Bradley, A. and Karsenty, G. (1996) Increased bone formation in osteocalcin-deficient mice. Nature, 382, 448-452.
69. Yagami, K., Suh, J.Y., Enomoto-Iwamoto, M., Koyama, E., Abrams, W.R., Shapiro, I.M. and Pacifici, M. (1999) Matrix GLA protein is a developmental regulator of chondrocyte mineralisation and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J. Cell Biol., 147, 1097-1108.
70. Zebboudj, A.F., Imura, M. and Bostrom, K. (2002) Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem., 277, 4388-4394.
71. Varghese, S., Rydziel, S. and Canalis, E. (2000) Basic fibroblast growth factor stimulates collagenase 3 promoter activity in osteoblasts through an activator protein-1 binding site. Endocrinology, 141, 2185-2191.
72. Jamsa, T., Jalovaara, P., Peng, Z., Vaananen, H.K. and Tuukkanen, J. (1998) Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone, 23, 155-161.
73. Akhter, M.P., Iwaniec, U.T., Covey, M.A., Cullen, D.M., Kimmel, D.B. and Recker, R.R. (2000) Genetic variations in bone density, histomorphometry and strength in mice. Cal. Tiss. Int., 67, 337-344.
74. Amizuka, N., Warshawsky, H., Henderson, J.E., Goltzman, D. and Karaplis, A.C. (1994) Parathyroid hormone-related peptide (PTHrP)-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol., 126, 1611-1623.
75. Henderson, J.E., Naski, M.C., Aarts, M., Wang, D., Cheng, L., Goltzman, D. and Ornitz, D.M. (2000) Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J. Bone. Miner. Res., 15, 155-165.
76. Aarts, M., Davidson, D., Corluka, A., Petroulakis, E., Guo, J., Bringhurst, F., Galipeau, J. and Henderson, J. (2001) PTHrP promotes quiescence and survival of serum deprived chondrocytes by inhibiting rRNA synthesis. J. Biol. Chem., 276, 37934-37943.
77. Windahl, S.H., Vidal, O., Andersson, G., Gustafkson, J.A. and Ohlsson, C. (1999) Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J. Clin. Invest., 104, 895-901.
78. Takahashi, F., Akutagawa, S., Fukumoto, H., Tsukiyama, S., Ohe, Y., Takahashi, K., Fukuchi, Y., Saijo, N. and Nishio, K. (2002) Osteopontin induces angiogenesis of murine neuroblastoma cells in mice. Int. J. Cancer, 98, 707-712.
79. Rahman, S., Oberdorf, A., Montecino, M., Tanhauser, S.M., Lian, J.B., Stein, G.S., Laipis, P.J. and Stein, J.L. (1993) Multiple copies of the bone specific osteocalcin gene in mouse and rat Endocrinology, 133, 3050-3053.
80. Newman, W., Gigout, L.I., Sudre, L., Grant, M.E. and Wallis, G.A. (2001) Coordinated expression of matrix Gla protein is requited during endochondral ossification for chondrocyte survival. J. Cell Biol., 154, 659-666.
81. Lipman, M.L., Panda, D., Bennett, H.P.J., Henderson, J.E., Shane, E., Shen, Y., Goltzman, D. and Karaplis, A.C. (1998) Cloning of human PEX cDNA: expression, subcellular localization and endopeptidase activity. J. Biol. Chem., 273, 13729-13737.